A. Gessain and O. Cassar, Epidemiological Aspects and World Distribution of HTLV-1 Infection, Front Microbiol, vol.3, p.388, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01370951

M. Iwanaga, T. Watanabe, and K. Yamaguchi, Adult T-cell leukemia: a review of epidemiological evidence, Front Microbiol, vol.3, p.322, 2012.

C. Bangham, A. Araujo, and Y. Yamano, HTLV-1-associated myelopathy/tropical spastic paraparesis, Nat Rev Dis Primer, vol.1, p.15012, 2015.
URL : https://hal.archives-ouvertes.fr/hal-00170972

E. Delaporte, A. Dupont, and M. Peeters, Epidemiology of HTLV-I in Gabon (Western Equatorial Africa), Int J Cancer, vol.42, pp.687-696, 1988.

J. Hesran, E. Delaporte, and C. Gaudebout, Demographic factors associated with HTLV-1 infection in a Gabonese community, Int J Epidemiol, vol.23, pp.812-819, 1994.

E. Delaporte, N. Monplaisir, and J. Louwagie, Prevalence of HTLV-I and HTLV-II infection in Gabon, Africa: comparison of the serological and PCR results, Int J Cancer, vol.49, pp.373-379, 1991.

D. D. Djuicy, A. Mouinga-ondémé, and O. Cassar, Risk factors for HTLV-1 infection in Central Africa: A rural populationbased survey in Gabon, PLoS Negl Trop Dis, vol.12, p.6832, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-02975273

M. Caron, G. Besson, and C. Padilla, Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis, PLoS Negl Trop Dis, vol.12, p.6833, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02481639

S. Etenna, M. Caron, and G. Besson, New Insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in Equatorial Central Africa, J Clin Microbiol, vol.46, pp.3607-3621, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00363876

P. Moukandja, I. Ngoungou, E. B. Lemamy, and G. J. , Nonmalarial infectious diseases of antenatal care in pregnant women in Franceville, BMC Pregnancy Childbirth, vol.17, p.185, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01634619

E. Delaporte, M. Peeters, and J. L. Bardy, Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa), J Acquir Immune Defic Syndr, vol.6, pp.424-432, 1993.

O. Gout, M. Baulac, and A. Gessain, Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation, N Engl J Med, vol.322, pp.383-391, 1990.

G. P. Taylor, Human T-lymphotropic virus type 1 infection and solid organ transplantation, Rev Med Virol, vol.28, p.1970, 2018.

S. Diop, S. Calattini, and J. Abah-dakou, Seroprevalence and molecular epidemiology of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal J Clin Microbiol, vol.44, pp.1550-1554, 2006.

E. S. Gudo, C. M. Abreu, and T. Mussá, Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique. Transfusion (Paris), vol.49, pp.1146-50, 2009.

M. Vermeulen, W. Sykes, and C. Coleman, The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in

, South African blood donors, Vox Sang, vol.114, pp.451-459, 2019.

R. Mahieux, F. Ibrahim, and P. Mauclere, Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies, J Virol, vol.71, pp.1317-1350, 1997.

F. Berteau, J. Mention, and J. Tissedre, Evaluation of the seroprevalence of human immunodeficiency virus (HIV) and human t-cell lymphotropic virus (HTLV) in Haut Ogooué Province in Gabon in pregnant women and blood donor control groups, Bull. Soc. Pathol. Exot, vol.86, pp.12-17, 1993.

A. M. Ngoma, M. D. Omokoko, and P. B. Mutombo, Seroprevalence of human T-lymphotropic virus (HTLV) in blood donors in sub-Saharan Africa: a systematic review and meta-analysis, Vox Sang, vol.114, pp.413-438, 2019.

A. Gessain, C. Fretz, and M. Koulibaly, Evidence of HTLV-II infection in Guinea, West Africa, J Acquir Immune Defic Syndr, vol.6, pp.324-329, 1993.

H. Vrielink, Y. Sisay, and H. W. Reesink, Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection, Transfus Med, vol.5, pp.135-142, 1995.

E. L. Murphy, Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety, Transfus Clin Biol J Soc Francaise Transfus Sang, vol.23, pp.13-22, 2016.

G. Marano, S. Vaglio, and S. Pupella, Human T-lymphotropic virus and transfusion safety: does one size fit all?, Transfusion (Paris), vol.56, pp.249-60, 2016.

H. Stigum, P. Magnus, and H. H. Samdal, Human T-cell lymphotropic virus testing of blood donors in Norway: a costeffect model, Int J Epidemiol, vol.29, pp.1076-84, 2000.

S. Zou, S. L. Stramer, and R. Y. Dodd, Donor testing and risk: current prevalence, incidence, and residual risk of transfusiontransmissible agents in US allogeneic donations, Transfus Med Rev, vol.26, pp.119-147, 2012.

C. E. Styles, C. R. Seed, and V. C. Hoad, Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia, Vox Sang, vol.112, pp.723-755, 2017.

M. Vermeulen, K. Van-den-berg, and W. Sykes, Health economic implications of testing blood donors in South Africa for HTLV 1 & 2 infection, Vox Sang, vol.114, pp.467-77, 2019.

A. Carneiro-proietti, E. C. Sabino, and S. Leão, Human T-lymphotropic virus type 1 and type 2 seroprevalence, incidence, and residual transfusion risk among blood donors in Brazil during, AIDS Res Hum Retroviruses, vol.28, pp.1265-72, 2007.

S. F. O'brien, M. Goldman, and V. Scalia, The epidemiology of human T-cell lymphotropic virus types I and II in Canadian blood donors, Transfus Med, vol.23, pp.358-66, 2013.

S. Laperche and J. Pillonel, Relevance of safety measures to avoid HTLV transmission by transfusion in 2014, Transfus. Clin. Biol

, J. Soc. Francaise Transfus. Sang, vol.21, pp.167-72, 2014.

C. R. Seed, A. R. Margaritis, and W. V. Bolton, Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays, Transfusion (Paris), vol.43, pp.226-260, 2003.

R. Thorstensson, J. Albert, and S. Andersson, Strategies for diagnosis of HTLV-I and -II, Transfusion (Paris), vol.42, pp.780-91, 2002.

P. E. Hewitt, K. Davison, and D. R. Howell, Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction, Transfusion (Paris), vol.53, pp.2168-75, 2013.

A. Manns, R. J. Wilks, and E. L. Murphy, A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion, Int J Cancer, vol.51, pp.886-91, 1992.

S. Kleinman, P. Swanson, and J. P. Allain, Transfusion transmission of human T-lymphotropic virus types I and II: serologic and polymerase chain reaction results in recipients identified through look-back investigations, Transfusion, vol.33, pp.14-22, 1993.

E. Donegan, H. Lee, and E. A. Operskalski, Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1, Transfusion, vol.34, pp.478-83, 1994.

C. Bartholomew, N. Jack, and J. Edwards, HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-Iassociated myelopathy/tropical spastic paraparesis, J Hum Virol, vol.1, pp.302-307, 1998.

F. Percher, P. Jeannin, and S. Martin-latil, Mother-to-child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother-to-child transmission, Viruses, vol.8, p.40, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01380761

P. N. Nyambi, Y. Ville, and J. Louwagie, Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years, J Acquir Immune Defic Syndr Hum Retrovirol, vol.12, pp.187-92, 1996.

S. Hino, Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki

, Proc Jpn Acad Ser B Phys Biol Sci, vol.87, pp.152-66, 2011.

A. J. Prendergast, A. E. Goga, and C. Waitt, Transmission of CMV, HTLV-1, and HIV through breastmilk, Lancet Child Adolesc Health, vol.3, pp.264-73, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02083455

N. Mojaat, H. Kaabi, and S. Hmida, Seroprevalence of HTLV-I/II antibodies in blood donors and different groups at risk in Tunisia, J Acquir Immune Defic Syndr, vol.22, pp.14-315, 1999.